Search

everythinglearnresearchcommunity

for

Search:↓

The research found that COVID-19 survivors experienced long-term effects like anemia and hypertension, with age and gender being important factors, but race, income, and education had little to no impact.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

Six months after COVID-19, most patients still had autoantibodies.

The document suggests using convalescent plasma to treat COVID-19 Long Hauler Syndromes because it may contain beneficial elements that target the virus.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Cancer patients with COVID-19 face higher risks due to possible additional infections.

During the COVID-19 lockdown, there were fewer cases of mild skin issues and more cases of stress-related skin conditions.

The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.

A global, inclusive approach is needed to address COVID-19 and protect vulnerable groups.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Most severe COVID-19 patients had hair loss, suggesting a possible link.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Social media data can help track and predict COVID-19 symptoms and trends.

Collider bias can distort our understanding of COVID-19 risk and severity.

Collider bias can mislead our understanding of COVID-19 risk and severity.

Age, health conditions, race, and gender affect COVID-19 risk.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Older age and existing health conditions increase COVID-19 death risk.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Insulin resistance linked to obesity may increase COVID-19 severity.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.